News & Analysis on Clinical Trial Services & Contract Research And Development
Silicon-based micro-machined devices for the controlled delivery of oral therapeutics, developed by Tejal Desai from the University of California, have won first prize at the 2006 Eurand Award Programme, impressing with their ability to combine...
According to the CEO and Chairman of pharmaceutical giant Eli Lilly, the biomedical breakthroughs that are occurring within the industry are transforming medicine and promise to ease the challenges facing an aging population.
The majority of pharmaceutical manufacturers who have adopted the lean manufacturing model are not satisfied with their results according to a new survey, raising questions about the efficacy of a system popular in the automotive and hi-tech industries.
Researchers think that they have developed an effective tactic, which aims to stop the spread of bacterial infections that have become resistant to antibiotic treatment paving the way for future therapies.
Ocean Optics introduces its new spectrometer, which combines low-cost with a small footprint that is designed for the budget conscious teaching and research labs.
Britain's manufacturers of tailor-made non-licensed medicines are working on establishing a unique supply agreement with major drug firms that could serve as a model worldwide for the production of drugs that meet the specialised medical needs of...
Drug development company Amphora Discovery has announced it is to split the company into two stand-alone business units - a pharmaceutical development firm in California and a contract research organisation in Durham.
Biotechnology firm Codexis says it has reached an important development milestone in its effort to design a biocatalytic process to produce a key intermediate for a Schering-Plough drug, reducing manufacturing costs and environmental waste.
A draft guidance has been published by the Food and Drug Administration (FDA) to help the industry wade through the potential minefield of conducting clinical research on patients without informed consent, in cases of emergencies.
A good selection process, with a realistic set of selection criteria is essential when looking for the right contract manufacturing partner, according to a new Datamonitor report.